Please login or register to print this page.

The British Journal
of Cardiology

This website is intended for healthcare professionals only

News and views

Br J Cardiol 2010;17:168-170

Report from the 20th Scientific Meeting of the European Society of Hypertension, Oslo, Norway

Report from the 20th Scientific Meeting of the European Society of Hypertension, Oslo, Norway

Renal denervation (RDN) revisited

A novel, catheter-based technique is looking promising for the treatment of refractory hypertension. Renal sympathetic hyperactivity is associated with the development of...

Read More

Br J Cardiol 2010;17:163-5

New NICE guidance on prevention of cardiovascular disease at the population level 

The National Institute for Health and Clinical Excellence (NICE) has published a new guidance on prevention of cardiovascular disease at the population level....

Read More

Br J Cardiol 2010;17:163-5

Testosterone trial stopped due to cardiovascular events 

A trial testing testosterone gel in older men with mobility limitations has been stopped early because of an increased risk of cardiovascular events in the...

Read More

Br J Cardiol 2010;17:163-5

Apixaban beneficial in atrial fibrillation 

A study of a new drug for atrial fibrillation, apixaban (Pfizer/Bristol-Myers Squibb), has been stopped early because of...

Read More

Br J Cardiol 2010;17:163-5

Eplerenone beneficial in mild heart failure 

Another trial stopped early because of benefit is EMPHASIS-HF (Eplerenone in Mild Patients Hospitalisation And SurvIval Study in Heart Failure) which looked at the aldosterone...

Read More

Br J Cardiol 2010;17:163-5

Treat individual risk factors not ‘metabolic syndrome’ 

A new study suggests that patients with metabolic syndrome are no more at risk of future myocardial infarction (MI) than those with diabetes or hypertension...

Read More

Br J Cardiol 2010;17:163-5

The British Valve Group – a new special interest group

The influence and importance of valve disease is increasing and yet the subject remains under-represented. There is, for example, no group affiliated to the British...

Read More

Br J Cardiol 2010;17:163-5

Lp(a) screening recommended by European Atherosclerosis Society 

Patients at moderate to high risk of cardiovascular disease should be screened for elevated Lp(a) and take niacin to lower levels to under 50 mg/dL...

Read More

Br J Cardiol 2010;17:163-5

England sees MI reduction after smoking ban 

A new study has confirmed that there has been a significant drop in hospital admissions for myocardial infarction (MI) after the introduction of smoke-free legislation...

Read More

Br J Cardiol 2010;17:167

In Brief

In Brief

News in brief from the world of cardiology....

Read More

Newsletter

Sign up for our regular email newsletter.


Print this page

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

Find out more about our membership benefits

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.

Find out more about our membership benefits